Novel insights into possible ZnO nanoparticle-induced changes in key metabolic enzymes in HeLa cervical cancer cell line
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Sirtuins and Resveratrol in Medicine · Genomics, phytochemicals, and oxidative stress
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Chen J et al (2015) Nanotechnology in the management of cervical cancer. Rev Med Virol 25:72–8310.1002/rmv.1825 ↗
2. Khan S et al (2017) Evaluation of in vitro cytotoxicity, biocompatibility, and changes in the expression of apoptosis regulatory proteins induced by cerium oxide nanocrystals. Sci Technol Adv Mater 18(1):364–37310.1080/14686996.2017.1319731 ↗
3. Al-Thani AN, Jan AG, Abbas M, Geetha M, Sadasivuni KK (2024) Nanoparticles in cancer theragnostic and drug delivery: a comprehensive review. Life Sci 352:12289910.1016/j.lfs.2024.122899 ↗
4. Khan S et al (2019) Preparation, characterizations and in vitro cytotoxic activity of nickel oxide nanoparticles on HT-29 and SW620 colon cancer cell lines. J Trace Elem Med Biol 52:12–1710.1016/j.jtemb.2018.11.003 ↗
5. Andleeb A et al (2021) A systematic review of biosynthesized metallic nanoparticles as a promising anti-cancer-strategy. Cancers (Basel) 13(11):281810.3390/cancers13112818 ↗
6. Pandurangan M, Enkhtaivan G, Kim DH (2016) Anticancer studies of synthesized ZnO nanoparticles against human cervical carcinoma cells. J Photochem Photobiol B 158:206–21110.1016/j.jphotobiol.2016.03.002 ↗
7. Akhtar MJ et al (2012) Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomed 845–85710.2147/IJN.S29129 ↗
8. Ansari AA et al (2020) In-vitro cytotoxicity evaluation of surface design luminescent lanthanide core/shell nanocrystals. Arab J Chem 13(1):1259–127010.1016/j.arabjc.2017.10.008 ↗
9. Wang J et al (2020) Highly water-soluble luminescent silica-coated cerium fluoride nanoparticles synthesis, characterizations, and in vitro evaluation of possible cytotoxicity. ACS Omega 5(30):19174–1918010.1021/acsomega.0c02551 ↗
10. Anjum S et al (2021) Recent advances in zinc oxide nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment. Cancers (Basel) 13(18):457010.3390/cancers13184570 ↗
11. Chen H et al (2021) Zinc oxide nanoparticles synthesized from Aspergillus terreus induces oxidative stress-mediated apoptosis through modulating apoptotic proteins in human cervical cancer HeLa cells. J Pharm Pharmacol 73(2):221–23210.1093/jpp/rgaa043 ↗
12. Wu H, Zhang J (2018) Chitosan-based zinc oxide nanoparticle for enhanced anticancer effect in cervical cancer: a physicochemical and biological perspective. Saudi Pharm J 26(2):205–21010.1016/j.jsps.2017.12.010 ↗
13. Asik RM (2018) Anticancer potential of Zinc oxide nanoparticles against cervical carcinoma cells synthesized via biogenic route using aqueous extract of Gracilaria edulis R. Mohamed Asik 2, 3, B. Gowdhami 2, 3, MS Mohamed Jabbir 4, G. Archunan 2, 3, N. Suganthy
14. Wei Y, Xiang H, Zhang W (2022) Review of various NAMPT inhibitors for the treatment of cancer. Front Pharmacol 13:97055310.3389/fphar.2022.970553 ↗
15. Gasparrini M, Audrito V (2022) NAMPT: a critical driver and therapeutic target for cancer. Int J Biochem Cell Biol 145:10618910.1016/j.biocel.2022.106189 ↗
16. Lucena-Cacace A et al (2018) NAMPT is a potent oncogene in colon cancer progression that modulates cancer stem cell properties and resistance to therapy through Sirt1 and PARP. Clin Cancer Res 24(5):1202–121510.1158/1078-0432.CCR-17-2575 ↗
17. Gasparrini M et al (2024) Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review. Expert Opin Ther Pat. https://doi.org/10.1080/13543776.2024.236700610.1080/13543776.2024.2367006 ↗
18. Chen A et al (2022) Prediction of cervical cancer outcome by identifying and validating a NAD+ metabolism-derived gene signature. J Pers Med 12(12):203110.3390/jpm12122031 ↗
19. Lin T-C (2022) Updated functional roles of NAMPT in carcinogenesis and therapeutic niches. Cancers (Basel) 14(9):205910.3390/cancers14092059 ↗
20. Jaiswal S et al (2025) Metabolomic profiling reveals grade-specific niacinamide accumulation and its therapeutic potential via SIRT1-CD38-EMT axis modulation in cervical cancer progression. Biochimica et Biophysica Acta (BBA)-Mol Cell Res 11999410.1016/j.bbamcr.2025.119994 ↗
21. Hong JY, Lin H (2021) Sirtuin modulators in cellular and animal models of human diseases. Front Pharmacol 12:73504410.3389/fphar.2021.735044 ↗
22. Wang M, Lin H (2021) Understanding the function of mammalian sirtuins and protein lysine acylation. Annu Rev Biochem 90(1):245–28510.1146/annurev-biochem-082520-125411 ↗
23. Yu L et al (2024) The dual role of sirtuins in cancer: biological functions and implications. Front Oncol. https://doi.org/10.3389/fonc.2024.138492810.3389/fonc.2024.1384928 ↗
24. Costa-Machado LF, Fernandez-Marcos PJ (2019) The sirtuin family in cancer. Cell Cycle 18(18):2164–219610.1080/15384101.2019.1634953 ↗
25. Singh S et al (2015) Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells. Tumor Biol 36:6159–617110.1007/s13277-015-3300-y ↗
26. Dogra S et al (2019) Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis. Nanomed Nanotechnol Biol Med 17:210–22210.1016/j.nano.2019.01.013 ↗
27. Li X et al (2022) SIRT1 protects against particulate matter-induced oxidative stress in human corneal and conjunctival epithelial cells. Invest Ophthalmol Vis Sci 63(10):19–1910.1167/iovs.63.10.19 ↗
28. Aventaggiato M et al (2022) Sirtuins and hypoxia in EMT control. Pharmaceuticals 15(6):73710.3390/ph15060737 ↗
29. Khoshmirsafa M et al (2022) Expression pattern of inflammatory and anti-inflammatory cytokines and key differential transcription factors in peripheral blood mononuclear cells of Iranian coronavirus disease 2019 patients with different disease severity. Viral Immunol 35(7):474–48210.1089/vim.2021.0224 ↗
30. Perumal P et al (2024) Green synthesis of zinc oxide nanoparticles using aqueous extract of shilajit and their anticancer activity against HeLa cells. Sci Rep 14(1):220410.1038/s41598-024-52217-x ↗
31. Wahab R et al (2011) Fabrication and growth mechanism of ZnO nanostructures and their cytotoxic effect on human brain tumor U87, cervical cancer HeLa, and normal HEK cells. JBIC Journal of Biological Inorganic Chemistry 16:431–44210.1007/s00775-010-0740-0 ↗
32. Moos PJ et al (2011) Responses of human cells to ZnO nanoparticles: a gene transcription study. Metallomics 3(11):1199–121110.1039/c1mt00061f ↗
33. Wang S-W et al (2020) ZnO nanoparticles induced caspase-dependent apoptosis in gingival squamous cell carcinoma through mitochondrial dysfunction and p70S6K signaling pathway. Int J Mol Sci 21(5):161210.3390/ijms21051612 ↗
34. Ye C et al (2020) Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level. Cell Commun Signal 18:1–1710.1186/s12964-020-0513-5 ↗
35. Anand AS et al (2023) Zinc oxide nanoparticles trigger dysfunction of mitochondrial respiratory complexes and repair dynamics in human alveolar cells. Toxicol Ind Health 39(3):127–13710.1177/07482337231152956 ↗
36. Imai S-I (2009) Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des 15(1):20–2810.2174/138161209787185814 ↗
37. Zhang W et al (2020) SIRT1 modulates cell cycle progression by regulating CHK2 acetylation− phosphorylation. Cell Death Differ 27(2):482–49610.1038/s41418-019-0369-7 ↗
38. Pan C-Y et al (2020) Zinc oxide nanoparticles modulate the gene expression of ZnT1 and ZIP8 to manipulate zinc homeostasis and stress-induced cytotoxicity in human neuroblastoma SH-SY5Y cells. PLoS One 15(9):e023272910.1371/journal.pone.0232729 ↗
39. Liang J et al (2022) The ZIP8/SIRT1 axis regulates alveolar progenitor cell renewal in aging and idiopathic pulmonary fibrosis. J Clin Investig 132(11)10.1172/JCI157338 ↗
40. Cameron SJ et al (2022) Nanoparticle effects on stress response pathways and nanoparticle–protein interactions. Int J Mol Sci 23(14):796210.3390/ijms23147962 ↗
41. An Y et al (2020) SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop. Cell Death Dis 11(2):11510.1038/s41419-020-2308-4 ↗
42. Yousefi A-M et al (2020) Zno/CNT@ Fe3O4 induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment. Artif Cells Nanomed Biotechnol 48(1):735–74510.1080/21691401.2020.1748885 ↗
43. Deng C-X (2009) SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 5(2):14710.7150/ijbs.5.147 ↗
44. Khorami S, Azizi R (2021) Effect of zinc on SIRT1 and PGC-1 alpha gene expression among ulcerative colitis patients. Academic Journal of Health Sciences: Medicina Balear 36(4):161–165
45. Wang Y et al (2019) SIRT2: controversy and multiple roles in disease and physiology. Ageing Res Rev 55:10096110.1016/j.arr.2019.100961 ↗
46. Li Y et al (2011) SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells 16(1):34–4510.1111/j.1365-2443.2010.01460.x ↗
47. Kozako T et al (2018) Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines. BMC Cancer 18:1–1010.1186/s12885-018-4710-1 ↗
48. Zu H et al (2022) SIRT2 functions as a histone delactylase and inhibits the proliferation and migration of neuroblastoma cells. Cell Discov 8(1):5410.1038/s41421-022-00398-y ↗
49. Carafa V, Altucci L, Nebbioso A (2019) Dual tumor suppressor and tumor promoter action of sirtuins in determining malignant phenotype. Front Pharmacol 10:3810.3389/fphar.2019.00038 ↗
50. Kumari P et al (2024) SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF. Proc Natl Acad Sci U S A 121(25):e240926912110.1073/pnas.2409269121 ↗
51. Mo Y et al (2017) SIRT 7 deacetylates DDB 1 and suppresses the activity of the CRL 4 E3 ligase complexes. FEBS J 284(21):3619–363610.1111/febs.14259 ↗
52. Liu X et al (2020) SIRT7 facilitates CENP-A nucleosome assembly and suppresses intestinal tumorigenesis. iScience. https://doi.org/10.1016/j.isci.2020.10146110.1016/j.isci.2020.101461 ↗
53. Guo J, Yuan Z, Wang R (2024) Zn2+ improves sepsis-induced acute kidney injury by up-regulating SIRT7-mediated Parkin acetylation. Am J Physiol-Renal Physiol10.1152/ajprenal.00337.2023 ↗
54. Velma GR et al (2024) Channeling nicotinamide phosphoribosyltransferase (NAMPT) to address life and death. J Med Chem 67(8):5999–602610.1021/acs.jmedchem.3c02112 ↗